our focus

Visus Therapeutics™ is a clinical-stage company dedicated to dramatically improving patient lives by developing differentiated, best-in-class ophthalmic therapies.

And we're just getting started...

Discover our pipeline today.

With officies in Seattle and Orange County, Visus is home to our lead clinical candidate, BRIMOCHOL™ (carbachol + brimonidine tartrate), an eye drop being evaluated to correct the loss of near vision associated with presbyopia.

About Main Photo

Visus Therapeutics is dedicated to helping the billions of adults who suffer from presbyopia through the development of its investigational medicine, BRIMOCHOL™.